VeriMomVeriMom

lysophosphatidic acid hamilelikte güvenli mi?

LPA is an endogenous signalling lipid with multiple peer‑reviewed studies showing roles in reproductive biology (endometrial decidualization, sperm viability and early developmental signalling) and animal models linking LPA signalling to developmental processes; this constitutes evidence of a plausible reproductive/developmental hazard (suspected). No EU Annex II/III listing or harmonised CLP (H360/H361) was found to override this, so scoring is 'suspected' rather than 'confirmed'. Sources: PubMed studies on LPA in decidualization and sperm viability, and ECHA registration/ingredient listings. (PubMed: LPA promotes endometrial decidualization; LPA regulates sperm viability).

İçerikler
lysophosphatidic acid
ORTA RISK
40
/100
0

Hamilelikte lysophosphatidic acid yerine kullanılabilecek güvenli alternatifler | VeriMom

Related ingredients

Frequently asked questions

lysophosphatidic acid hamilelikte güvenli mi?
LPA is an endogenous signalling lipid with multiple peer‑reviewed studies showing roles in reproductive biology (endometrial decidualization, sperm viability and early developmental signalling) and animal models linking LPA signalling to developmental processes; this constitutes evidence of a plausible reproductive/developmental hazard (suspected). No EU Annex II/III listing or harmonised CLP (H360/H361) was found to override this, so scoring is 'suspected' rather than 'confirmed'. Sources: PubMed studies on LPA in decidualization and sperm viability, and ECHA registration/ingredient listings. (PubMed: LPA promotes endometrial decidualization; LPA regulates sperm viability).
lysophosphatidic acid emzirirken güvenli mi?
Mechanistic and animal/biological data show LPA activity relevant to reproductive tissues and germ cells; while direct human lactational transfer studies were not located, the biological activity supports a similar 'suspected' hazard ranking for lactation exposure. No regulatory ban or harmonised lactation-specific classification was found. Dermal-to-systemic transfer data are lacking, so exposure is scored as low but measurable. Sources: PubMed LPA signalling papers and ECHA/CosIng listings.
lysophosphatidic acid bebek cildi için güvenli mi?
Hazard and mechanism scores mirror adult pregnancy/breastfeeding because the toxicology/biological signalling evidence is not infant‑specific, but exposure (e) is increased by +1 for infants due to immature barrier and higher surface-area-to-weight ratio. No infant-specific toxicokinetic studies were found. Sources: PubMed LPA literature; CosIng/ECHA ingredient pages.
VeriMom lysophosphatidic acid nasıl puanlıyor?
VeriMom lysophosphatidic acid'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 40/100 (orta risk) olarak puanlar.
Hamilelikte lysophosphatidic acid yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin